# Prophylactic Effects of Agomelatine for Poststroke Depression

Study · id `cardio:ct-nct05426304` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05426304](<https://clinicaltrials.gov/study/NCT05426304>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05426304

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 420 participants.

## Technical summary

Registry record NCT05426304. Randomized; quadruple masking; primary purpose prevention. Start 2022-10-01 (anticipated); primary completion 2024-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 420 participants (planned count; ClinicalTrials.gov record NCT05426304, source copy `cardio:ctgov-nct05426304-2022-07-27`, retrieved 2026-10-26)
- Planned start: 2022-10-01 (anticipated) (ClinicalTrials.gov record NCT05426304, source copy `cardio:ctgov-nct05426304-2022-07-27`, retrieved 2026-10-26)
- Primary completion: 2024-05-31 (anticipated) (ClinicalTrials.gov record NCT05426304, source copy `cardio:ctgov-nct05426304-2022-07-27`, retrieved 2026-10-26)
- Completion: 2024-05-31 (anticipated) (ClinicalTrials.gov record NCT05426304, source copy `cardio:ctgov-nct05426304-2022-07-27`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05426304-2022-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prophylactic Effects of Agomelatine for Poststroke Depression
- Acronym: PRAISED
- Condition: Depression
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Agomelatine
- Intervention (Drug): Placebo Tablets
- Lead sponsor: First Affiliated Hospital, Sun Yat-Sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital, Sun Yat-Sen University (`cardio:org-first-affiliated-hospital-sun-yat-sen-university`)

## Provenance

Content hash: 91632f240a8ee2c895cfee2634ebe0b90a7b13b0358f8b0b496ac162ce9228ca
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
